Pfizer, Inc. (NYSE:PFE).
Gateway Investment Advisers LLC reports that it lowered its stake in Pfizer, Inc. by 66,188 shares in its quarterly SEC filing. Its position was worth $106,661,000 a decrease of 3.8% as of the end of the quarter.
Other firms have also shifted positions in (PFE). Pennsylvania Trust Co added to its holdings by buying 174,867 shares an increase of 37.7% from 03/31/2017 to 06/30/2017. Pennsylvania Trust Co now holds 638,149 shares with a value of $21,444,000. The total value of its holdings increased 35.3%. As of quarter end Narwhal Capital Management had bought 20,025 shares growing its position 14.3%. The value of the investment in PFE increased from $4,790,000 to $5,376,000 a change of 12.2% for the reporting period.
Banced Corp divested its stake by selling 2,531 shares a decrease of 8.5% in the quarter. Banced Corp claims 27,357 shares valued at $919,000. The value of the position overall is down by 10.1%.
On May 16 the stock rating was downgraded to “Sell” from “Buy” by analysts at Citigroup. Guggenheim added PFE to its research portfolio setting a rating of “Neutral”.
On November 29 the company was set at “Overweight” in a report from Barclays which was a boost from the previous “Equal-weight” rating. On November 2 the company was downgraded from “Outperform” to “Market Perform” in an announcement from Argus.
On November 2, 2016 the stock rating was rated “Market Perform” by BMO Capital down from the previous “Outperform” rating. On October 13 the stock rating was downgraded from “Buy” to “Hold” in a statement from Jefferies.
The company is so far trading up from yesterday’s close of $33.17. The company also recently declared a dividend to be paid on Friday the 1st of September 2017. The dividend will be $0.320 per share for the quarter which is $1.28 annualized. This dividend represents a yeild of $3.84 which is the dividend as a percentage of the current share price. The ex-dividend date will be Wednesday May 10th, 2017.
Shares last traded at $33.40 which is a tad above $32.80, the 50 day moving average and a bit higher than the 200 day moving average of $33.17. The 50 day moving average went up by +1.61% and the 200 day average went up $0.16 or +0.49%.
The most current P/E ratio is 28.06 and the market value is 198.91B. In the last earnings report the EPS was $1.19 and is estimated to be $2.55 for the current year with 5,967,844,000 shares outstanding. Analysts expect next quarter’s EPS to be $0.64 and the next full year EPS is anticipated to be $2.74.